跳至主要内容
临床试验/NCT07451522
NCT07451522招募中不适用

Comparative Characteristics of Analgesia Methods in the Early Postoperative Period After Coronary Artery Bypass Grafting (CABG)

Primorsky Regional General Hospital #11 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年12月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
Visual Analogue Scale (VAS)

研究概览

简要总结

The goal of this clinical trial is to study postoperative analgesia in patients undergoing CABG. And learn if tafalgin (tyrosyl-D-arginyl-phenylalanyl-glycine amid) treats pain not inferiory then morphine. The main questions it aims to answer are:

Does tafalgin (tyrosyl-D-arginyl-phenylalanyl-glycine amid) lower the VAS score same way as a morphine? What medical problems do participants have when taking tafalgin (tyrosyl-D-arginyl-phenylalanyl-glycine amid)?

Participants will:

Group (1)- subcutaneous single dose of morphine 10 mg would be administred based on VAS score > 3 during 24 hours after CABG.

Exprimental group (2)- subcutaneous single dose of tafalgin (tyrosyl-D-arginyl-phenylalanyl-glycine amid) - 0.4 mg would be administred based on VAS score > 3 during 24 hours after CABG.

Efficacy was assessed using the VAS scale decreassion. Hemodynamic parameters and arterial blood gases were also assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA score less then 3, Signed inform consent, Absence of preoperative drugs administration that affects patient's perception of pain, No active infection process, BMI index >18,5 kg\m2 and < 35 kg/m2, CABG, Age 18-75 years

排除标准

  • (the presence of at least one is sufficient):
  • Failure to meet the inclusion criteria.
  • High severity according to ASA (class IV or higher), which is associated with a high probability of prolonged mechanical ventilation, hemodynamic instability, and inability to use drugs affecting cardiac output and/or total peripheral vascular resistance.
  • Contraindications to the use of tafalgin and/or morphine in accordance with the approved Summary of Product Characteristics (hypersensitivity to tafalgin, morphine, other opioids, or any excipients).
  • Pregnancy or lactation.
  • Acute or prolonged chronic intoxication with drugs or substances depressing the central nervous system (alcohol, barbiturates, opioid drugs, benzodiazepines).
  • Use of monoamine oxidase inhibitors (MAOIs) or less than 14 days since their discontinuation.
  • Liver cirrhosis, Child-Pugh class C.
  • Acute renal failure requiring renal replacement therapy.
  • Unresected malignant neoplasm.
  • Mesenteric thrombosis or another severe abdominal pain syndrome of unclear etiology at the time of inclusion.
  • Simultaneous participation in another clinical study.
  • Marked CNS depression due to any cause, except for acute poisoning.
  • COPD stage III and/or bronchial asthma in the exacerbation phase.
  • Any clinically significant condition, disease, or circumstance in the medical history that, in the opinion of the investigator, precludes participation in the study.
  • Psychiatric, physical, or other conditions preventing adequate assessment of the patient's behavior or proper compliance with the study protocol.
  • Postoperative hemodynamic instability requiring high-dose inotropic and/or vasopressor support (epinephrine > 0.1 μg/kg/min, dopamine > 10 μg/kg/min, norepinephrine > 0.2 μg/kg/min) and/or mechanical circulatory support.
  • Refusal to participate in the study.

研究组 & 干预措施

Morphine

Active Comparator

Patients after CABG with morphine postoperative analgesia

干预措施: Morphine (+) (Drug)

Tafalgin (tyrosyl-D-arginyl-phenylalanyl-glycine amide)

Experimental

Patients after CABG with tafalgin postoperative analgesia

干预措施: Tafalgin (tyrosyl-D-arginyl-phenylalanyl-glycine amide) (Drug)

结局指标

主要结局

Visual Analogue Scale (VAS)

时间窗: 24 hours after CABG

The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression or compare pain severity between patients

次要结局

  • Arterial Blood Gases (ABGs) pH(24 hours after CABG)
  • Arterial Blood Gases (ABGs) oxygen (PaO2) levels(24 hours after CABG)
  • Arterial Blood Gases (ABGs) carbon dioxide (PaCO2) levels(24 hours after CABG)
  • Haemodynamics evaluation (Intra-arterial blood pressure (IABP))(24 hours after CABG)
  • Haemodynamics evaluation (Heart rate (HR))(24 hours after CABG)

研究者

发起方
Primorsky Regional General Hospital #1
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Vladislav Rublev

Head of EP, Principal Investigator, MD, PhD

Primorsky Regional General Hospital #1

研究点 (1)

Loading locations...

相似试验

Comparative Analysis of Analgesic Approaches in the... | 临床试验